Does medication Adherence Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes?
Medication adherence failed to explain observed racial differences in the achievement of HbA1c, LDL-C, and SBP control among insured patients with diabetes.
Combined immunohistochemical assessment of PR and PTEN may help identify a small subset of PanNETs with more aggressive behavior and may aid in risk stratification.